10-K/A XBRL

FORM 10-K/A

Company: Cellectar Biosciences, Inc.
Filed: April 1, 2024
Period of Report: December 31, 2023
Accession Number: 0001104659-24-041930

View Document ↗ View on SEC.gov ↗